Asia Pacific Nebulizer Market Size & Outlook, 2023-2030
Asia Pacific nebulizer market, 2018-2030 (US$M)
Related Markets
Asia Pacific nebulizer market highlights
- The Asia Pacific nebulizer market generated a revenue of USD 283.6 million in 2023.
- The market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, jet was the largest revenue generating type in 2023.
- Mesh is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Philippines is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 283.6 million |
| Market revenue in 2030 | USD 472.7 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Jet |
| Fastest growing segment | Mesh |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Jet, Mesh, Ultrasonic |
| Key market players worldwide | OMRON Corp, GE HealthCare Technologies Inc Common Stock, Koninklijke Philips NV, Allied Healthcare Products Inc, DeVilbiss Healthcare, Briggs Healthcare Corp., Beurer, PARI Group, Philip Morris International Inc, Aerogen |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 24.5% of the global nebulizer market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 472.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nebulizer Market Scope
Nebulizer Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific nebulizer market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nebulizer market will help companies and investors design strategic landscapes.
Jet was the largest segment with a revenue share of 65.2% in 2023. Horizon Databook has segmented the Asia Pacific nebulizer market based on jet, mesh, ultrasonic covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific comprises Japan, India, and China. China accounts for the largest market share in this region. A significant rise in geriatric population is boosting the growth of the nebulizers market in Japan. According to Japan’s Ministry of Health, Labor and Welfare, COPD is the seventh most common cause of death in the country.
In addition, According to WHO, as of 2017, approximately 90.0% of the total number of deaths due to COPD occurred in middle- and low-income countries. It also stated that countries such as China and India single-handedly accounted for about 66.0% of the total number of deaths due to COPD.
Low-cost manufacturing sites and favorable taxation policies attract global players to enter the lucrative market in these countries. Chinese healthcare reforms are the most notable. In addition, rise in medical tourism in countries such as India, the Philippines, Malaysia, and Singapore is contributing to the overall growth of the market in Asia Pacific.
Reasons to subscribe to Asia Pacific nebulizer market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific nebulizer market databook
-
Our clientele includes a mix of nebulizer market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific nebulizer market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific nebulizer market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific nebulizer market size, by country, 2018-2030 (US$M)
Asia Pacific Nebulizer Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
